Guru Ownership Trend
Guru Analysis for Cardiff Oncology, Inc. (CRDF)
Cardiff Oncology, Inc. (CRDF), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $217,631.7.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $271,203 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Cardiff Oncology, Inc. (CRDF)
Major holders include Renaissance Technologies (RenTech) ($164,030), Cliff Asness ($107,173). According to the latest reported data, 2 tracked investment managers collectively hold approximately 167,409 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $271,203, with 2 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in CRDF during the most recent reporting period.
Yes, 2 managers opened new positions in CRDF, and 0 increased their existing holdings. The total reported buy value was $271,203.